查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1945792

CBD膳食補充品市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、通路、地區及競爭格局分類，2021-2031年）

CBD Nutraceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球 CBD 膳食補充劑市場預計將從 2025 年的 50.9 億美元成長到 2031 年的 102.8 億美元，複合年成長率為 12.43%。

該行業涵蓋多種健康產品，包括以工業大麻提取的大麻二酚 (CBD) 配製的機能性食品、飲料和膳食補充劑。這些產品旨在提供諸如緩解壓力和改善睡眠等治療功效，且不具有任何精神活性作用。這一成長主要得益於消費者對預防醫學態度的根本性轉變，以及對天然植物性替代傳統藥物需求的日益成長。根據美國大麻圓桌會議的數據，作為全球市場的重要支柱，美國大麻產業預計在2024年將創造約284億美元的收入。

市場概覽
預測期 2027-2031
市場規模：2025年 50.9億美元
市場規模：2031年 102.8億美元
複合年成長率：2026-2031年 12.43%
成長最快的細分市場 網路藥房
最大的市場 北美洲

然而，市場擴張的一大障礙是各國監管法規的零碎化。各國在CBD含量標準、標示要求以及CBD作為藥品或食品的分類等方面的法律法規存在差異，導致合規環境複雜。這些不一致之處不僅使國際貿易困難重重，也限制了製造商獲得關鍵金融服務，包括銀行和支付處理服務。

市場促進因素

消費者對CBD（大麻二酚）保健功效的認知不斷提高，正從根本上改變著全球CBD膳食補充劑市場，使其從一種特殊產品躍升為一種標準的健康必需品。隨著大眾對大麻非精神活性特性的了解不斷加深，越來越多的人群開始積極尋求植物來源解決方案來緩解慢性疼痛、焦慮和改善睡眠。這種態度的轉變體現在其高使用率：根據2024年4月《福布斯健康》雜誌發表的題為“2024年CBD統計數據、資訊和使用情況”的報導，60%的美國成年人使用過或嘗試過CBD產品。這種廣泛的普及促使製造商突破傳統酊劑的限制，為這個精明的消費群體開發專門的膳食補充劑。

電子商務和主流零售通路的擴張是推動成長的第二個主要動力，有效消除了獲取障礙。 CBD產品從專賣店過渡到大型零售商的過渡顯著提升了消費者的信任度和品牌知名度。 Charlotte's Web Holdings, Inc. 就是一個鮮明的例子。該公司在2024年11月發布的2024年第三季財報中宣布與沃爾瑪達成零售擴張合作，將CBD外用產品引進827家門市。此外，CV Sciences, Inc. 在2024年11月發布的2024年第三季財報中實現了46.0%的毛利率，顯示其業務營運日益穩定，也顯示即使監管環境複雜，CBD市場仍能維持盈利。

市場挑戰

監管分散化是目前全球CBD膳食補充劑市場成長的最大障礙。由於缺乏統一的法律體制，製造商被迫在錯綜複雜的相互衝突的法規網路中運營，不同司法管轄區對產品分類和允許的THC含量差異顯著。這種不一致擾亂了全球供應鏈，並推高了遵循成本，因為企業必須頻繁地重新配製產品並調整包裝以滿足不同的地區要求。此外，主要經濟體中這些產品的法律地位存在不確定性，造成了高風險環境，阻礙了機構投資，限制了企業獲得關鍵銀行服務的管道，從而抑制了創新和資本流動。

這種監管不確定性的影響深遠，對現有產業相關人員構成生存威脅。正如美國大麻圓桌會議在2024年報告所述，由於缺乏明確的聯邦定義，提案的限制性法律改革有可能實際上禁止市場上約95%的大麻萃取物產品。這種巨大的不確定性阻礙了企業實施長期成長計劃，並限制了該行業從利基市場發展成為全球健康經濟中完全融合的組成部分的能力。

市場趨勢

將CBG和CBN等微量大麻素添加到產品配方中，正在重塑產業內的差異化策略。我們正從泛泛的健康聲明轉向滿足特定的生理需求。製造商正在分離這些微量大麻素，開發專門用於改善注意力和睡眠的輔助產品，利用與CBD協同作用的「協同效應」來增強治療效果。這種向更先進成分的轉變在近期針對失眠等慢性問題的創新中顯而易見。例如，在2024年3月題為「Charlotte's Web推出助眠CBN軟糖」的新聞稿中，Charlotte's Web Holdings宣布推出一款針對特定症狀的配方，其中包含精確劑量的20毫克CBN，經臨床設計，旨在幫助睡眠障礙患者。

消費者偏好的轉變也促使他們更青睞可食用軟糖產品而非傳統的舌下酊劑，更重視口感與便利性。這一趨勢正推動各公司調整產品線，以滿足消費者對糖果甜點式服用方式的需求，這種服用方式能夠無縫融入日常生活，同時避免膠囊和油劑帶來的醫療聯想。消費者對可食用產品的偏好也為專注於此類創新的品牌帶來了強勁的財務表現。根據Flora Growth於2024年8月發布的2024年第二季財務報告，其子公司Just CBD的銷售額達440萬美元，毛利率高達34%，這一業績顯然得益於其軟糖產品線的高銷量。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球CBD膳食補充品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（CBD酊劑、膠囊/軟膠囊、CBD軟糖、其他）
    • 按分銷管道（醫院藥房、零售藥房、網路藥房）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美CBD膳食補充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲CBD膳食補充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區CBD膳食補充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲CBD膳食補充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲CBD膳食補充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球CBD膳食補充品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Gaia Botanicals LLC
  • CV Sciences, Inc.
  • Elixinol LLC
  • Garden of Life
  • Isodiol International Inc
  • Medical Marijuana Inc
  • Medterra

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19545

The Global CBD Nutraceuticals Market is projected to expand from USD 5.09 Billion in 2025 to USD 10.28 Billion by 2031, reflecting a CAGR of 12.43%. This sector encompasses a variety of wellness products, such as functional foods, beverages, and dietary supplements infused with industrial hemp-derived cannabidiol, which are designed to offer therapeutic advantages like stress reduction and better sleep without psychoactive effects. This growth is largely fueled by a fundamental consumer shift towards preventative health measures and a rising demand for natural, plant-based substitutes for conventional medicines. Data from the U.S. Hemp Roundtable indicates that the U.S. hemp industry, a key pillar of the global market, generated roughly $28.4 billion in revenue during 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.09 Billion
Market Size 2031USD 10.28 Billion
CAGR 2026-203112.43%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Nevertheless, a major obstacle hindering widespread market growth is the ongoing regulatory fragmentation across different nations. Conflicting legal frameworks concerning allowed CBD levels, labeling mandates, and categorization as either medicine or food establish a difficult compliance environment. This inconsistency complicates international commerce and limits manufacturers' access to vital financial services, including banking and payment processing.

Market Driver

Increasing consumer knowledge regarding therapeutic health advantages is fundamentally transforming the Global CBD Nutraceuticals Market, elevating cannabidiol from a specialized product to a standard wellness essential. As the public gains a better understanding of hemp's non-psychoactive attributes, a larger demographic is actively pursuing plant-based solutions for chronic pain, anxiety, and sleep management. This change in attitude is reflected in high usage rates; according to an April 2024 Forbes Health article titled 'CBD Statistics, Data And Use In 2024', 60% of adults in the U.S. have used or tried a CBD product. Such widespread adoption is prompting manufacturers to innovate past basic tinctures, creating specialized nutraceuticals for an increasingly informed customer base.

The broadening of e-commerce and mainstream retail distribution channels acts as the second major catalyst for growth, effectively removing accessibility hurdles. Moving CBD products from exclusive dispensaries to major retailers has notably improved consumer confidence and brand exposure. A significant illustration of this shift occurred when Charlotte's Web Holdings Inc., in its 'Reports 2024 Third Quarter Financial Results' from November 2024, announced an expanded retail footprint through a partnership with Walmart, placing CBD topicals in 827 additional locations. Additionally, demonstrating improved operational stability, CV Sciences, Inc. reported a gross margin of 46.0% in its 'Reports Third Quarter 2024 Financial Results' in November 2024, indicating a maturing market able to maintain profitability despite regulatory complexities.

Market Challenge

Regulatory fragmentation constitutes the most significant obstacle currently holding back the Global CBD Nutraceuticals Market's growth. The lack of a cohesive legal structure compels manufacturers to operate within a complicated mix of conflicting regulations, where product classifications and allowable THC levels vary widely across jurisdictions. These inconsistencies interrupt global supply chains and drive up compliance expenses, as businesses are forced to frequently reformulate products and adjust packaging to satisfy differing regional requirements. Moreover, the uncertain legal standing of these items in key economies fosters a high-risk atmosphere that deters institutional investment and limits access to critical banking services, hindering innovation and capital movement.

The consequences of this regulatory volatility are profound, posing existential threats to established industry participants. As reported by the U.S. Hemp Roundtable in 2024, restrictive legislative changes proposed due to the absence of precise federal definitions risked effectively banning roughly 95% of all hemp extract products available on the market. Such intense uncertainty stops companies from implementing long-term growth plans and restricts the sector's capacity to evolve from a niche market into a fully integrated element of the global wellness economy.

Market Trends

The rise of minor cannabinoids such as CBG and CBN in product formulations is actively reshaping differentiation strategies within the industry, moving beyond general wellness assertions to address specific physiological needs. Manufacturers are increasingly isolating these minor cannabinoids to create distinct aids for focus and sleep, leveraging the "entourage effect" where these compounds function synergistically with CBD to improve therapeutic results. This move towards sophisticated ingredients is highlighted by recent innovations aimed at chronic issues like insomnia; for instance, Charlotte's Web Holdings, Inc. announced in a March 2024 press release titled 'Charlotte's Web Launches Stay Asleep CBN Gummies' the launch of a condition-specific formula providing a precise 20 mg dose of CBN, clinically designed to assist consumers with sleep disruptions.

A parallel shift in consumer preference is seen in the growing dominance of edible and gummy formats, which prioritize taste and convenience over conventional sublingual tinctures. This trend is driving companies to reorganize their product offerings, as customers prefer familiar, confectionery-style delivery methods that fit easily into daily life without the medicinal stigma linked to capsules or oils. This preference for edibles is resulting in strong financial outcomes for brands focusing on such innovations; according to Flora Growth Corp.'s 'Reports Second Quarter 2024 Financial Results' from August 2024, its JustCBD subsidiary sustained a robust gross profit margin of 34% on sales of $4.4 million, a performance explicitly attributed to the high sales volume of its gummy product lines.

Key Market Players

  • Gaia Botanicals LLC
  • CV Sciences, Inc.
  • Elixinol LLC
  • Garden of Life
  • Isodiol International Inc
  • Medical Marijuana Inc
  • Medterra

Report Scope

In this report, the Global CBD Nutraceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

CBD Nutraceuticals Market, By Product Type

  • CBD Tinctures
  • Capsules & Softgels
  • CBD Gummies
  • Others

CBD Nutraceuticals Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

CBD Nutraceuticals Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global CBD Nutraceuticals Market.

Available Customizations:

Global CBD Nutraceuticals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global CBD Nutraceuticals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (CBD Tinctures, Capsules & Softgels, CBD Gummies, Others)
    • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America CBD Nutraceuticals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States CBD Nutraceuticals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada CBD Nutraceuticals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico CBD Nutraceuticals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Distribution Channel

7. Europe CBD Nutraceuticals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany CBD Nutraceuticals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. France CBD Nutraceuticals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom CBD Nutraceuticals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy CBD Nutraceuticals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain CBD Nutraceuticals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Distribution Channel

8. Asia Pacific CBD Nutraceuticals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China CBD Nutraceuticals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India CBD Nutraceuticals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan CBD Nutraceuticals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea CBD Nutraceuticals Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia CBD Nutraceuticals Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Distribution Channel

9. Middle East & Africa CBD Nutraceuticals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia CBD Nutraceuticals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. UAE CBD Nutraceuticals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. South Africa CBD Nutraceuticals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Distribution Channel

10. South America CBD Nutraceuticals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil CBD Nutraceuticals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Colombia CBD Nutraceuticals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. Argentina CBD Nutraceuticals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global CBD Nutraceuticals Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Gaia Botanicals LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. CV Sciences, Inc.
  • 15.3. Elixinol LLC
  • 15.4. Garden of Life
  • 15.5. Isodiol International Inc
  • 15.6. Medical Marijuana Inc
  • 15.7. Medterra

16. Strategic Recommendations

17. About Us & Disclaimer